Thrivent Financial for Lutherans Portfolio holdings
AUM
$45.7B
1-Year Return
20.42%
This Quarter Return
+2.4%
1 Year Return
+20.42%
3 Year Return
+83.29%
5 Year Return
+151.37%
10 Year Return
+389.71%
AUM
$51.6B
AUM Growth
-$1.03B
(-2%)
Cap. Flow
-$1.33B
Cap. Flow
% of AUM
-2.57%
Top 10 Holdings %
Top 10 Hldgs %
17.59%
Holding
2,634
New
128
Increased
809
Reduced
1,536
Closed
86
Top Buys
| 1 |
Old Dominion Freight Line
ODFL
|
$101M |
| 2 |
Nike
NKE
|
$99.4M |
| 3 |
UnitedHealth
UNH
|
$98.4M |
| 4 |
Neurocrine Biosciences
NBIX
|
$97.2M |
| 5 |
Broadcom
AVGO
|
$91.2M |
Top Sells
| 1 |
Walmart
WMT
|
$155M |
| 2 |
Option Care Health
OPCH
|
$134M |
| 3 |
Advanced Drainage Systems
WMS
|
$133M |
| 4 |
NOV
NOV
|
$104M |
| 5 |
Halliburton
HAL
|
$102M |
Sector Composition
| 1 | Technology | 20.47% |
| 2 | Financials | 11.83% |
| 3 | Consumer Discretionary | 10.57% |
| 4 | Industrials | 10.17% |
| 5 | Healthcare | 8.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
J&J Snack Foods
JJSF
$2.12B
| $100M | 0.19% |
645,005
+2,357
| +0.4% | +$366K |
|
127
Haemonetics
HAE
$2.62B
| $98.7M | 0.19% |
1,264,294
+164,111
| +15% | +$12.8M |
|
128
iShares Core US Aggregate Bond ETF
AGG
$131B
| $98.6M | 0.19% |
1,007,886
-67,048
| -6% | -$6.56M |
|
129
Comcast
CMCSA
$125B
| $98.4M | 0.19% |
2,614,818
-200,177
| -7% | -$7.54M |
|
130
Public Service Enterprise Group
PEG
$40.5B
| $97.1M | 0.19% |
1,149,592
-38,964
| -3% | -$3.29M |
|
131
National Storage Affiliates Trust
NSA
$2.56B
| $96.6M | 0.19% |
2,548,145
+10,783
| +0.4% | +$409K |
|
132
General Dynamics
GD
$86.8B
| $96.1M | 0.19% |
363,920
-10,056
| -3% | -$2.66M |
|
133
Vanguard Value ETF
VTV
$143B
| $96M | 0.19% |
565,329
+52,285
| +10% | +$8.88M |
|
134
Humana
HUM
$37B
| $95.7M | 0.19% |
377,197
-223,120
| -37% | -$56.6M |
|
135
Thrivent Small-Mid Cap ESG ETF
TSME
$548M
| $95.6M | 0.19% |
2,606,925
+744,928
| +40% | +$27.3M |
|
136
Nucor
NUE
$33.8B
| $94.9M | 0.18% |
810,965
-472,146
| -37% | -$55.2M |
|
137
Northrop Grumman
NOC
$83.2B
| $94.6M | 0.18% |
201,377
-5,659
| -3% | -$2.66M |
|
138
Sanofi
SNY
$113B
| $93.8M | 0.18% |
1,943,761
+514,542
| +36% | +$24.8M |
|
139
Labcorp
LH
$23.2B
| $92.4M | 0.18% |
402,958
-346,310
| -46% | -$79.4M |
|
140
Radian Group
RDN
$4.79B
| $92M | 0.18% |
2,900,539
-46,447
| -2% | -$1.47M |
|
141
Fidelity Blue Chip Growth ETF
FBCG
$4.66B
| $91M | 0.18% |
1,967,967
+95,106
| +5% | +$4.4M |
|
142
Crown Castle
CCI
$41.9B
| $90.6M | 0.18% |
997,800
-61,500
| -6% | -$5.58M |
|
143
iShares MSCI Emerging Markets ex China ETF
EMXC
$13B
| $90.2M | 0.17% |
1,593,249
+285,997
| +22% | +$16.2M |
|
144
Regeneron Pharmaceuticals
REGN
$60.8B
| $89.2M | 0.17% |
125,194
+116,074
| +1,273% | +$82.7M |
|
145
Zimmer Biomet
ZBH
$20.9B
| $88.7M | 0.17% |
839,461
-28,859
| -3% | -$3.05M |
|
146
Equinix
EQIX
$75.7B
| $88.3M | 0.17% |
93,661
-58,780
| -39% | -$55.4M |
|
147
MetLife
MET
$52.9B
| $88.2M | 0.17% |
1,077,214
-39,281
| -4% | -$3.22M |
|
148
Robert Half
RHI
$3.77B
| $87.8M | 0.17% |
1,246,675
+2,335
| +0.2% | +$165K |
|
149
Penumbra
PEN
$11B
| $87.3M | 0.17% |
367,661
-637
| -0.2% | -$151K |
|
150
Repligen
RGEN
$7.01B
| $87.1M | 0.17% |
605,120
-33,482
| -5% | -$4.82M |
|